Trials / Completed
CompletedNCT00424372
A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia
A LONG-TERM STUDY TO EVALUATE SAFETY AND EFFICACY STUDY OF PREGABALIN IN THE TREATMENT OF POSTHERPETIC NEURALGIA.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 126 (actual)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety of the long-term use of pregabalin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pregabalin | Dosage: 150-600 mg/day (75-300 mg bid), oral administration, Treatment duration: 52 weeks |
Timeline
- Start date
- 2007-01-12
- Primary completion
- 2008-08-19
- Completion
- 2008-08-19
- First posted
- 2007-01-19
- Last updated
- 2021-08-27
- Results posted
- 2009-09-28
Locations
33 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00424372. Inclusion in this directory is not an endorsement.